Kolexia
Lapeyre-Mestre Maryse
Santé publique
Hôpital Purpan
Toulouse, France
515 Activités
96 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thrombopénie Purpura thrombopénique idiopathique Troubles liés à une substance Effets secondaires indésirables des médicaments Troubles liés aux opiacés Démence Thrombose Maladie d'Alzheimer Purpura

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study.
Cancer treatment and research communications   29 février 2024
Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network.
Fundamental & clinical pharmacology   19 février 2024
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.
British journal of haematology   24 janvier 2024
Which factors preceding dementia identification impact future healthcare use trajectories: multilevel analyses in administrative data.
BMC geriatrics   23 janvier 2024
Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in France
65th ASH Annual Meeting Abstracts   02 novembre 2023
Analgesic switching in chronic users of dextropropoxyphene in France.
Fundamental & clinical pharmacology   21 octobre 2023
Use of baclofen for the treatment of alcohol use disorders between 2014 and 2021 in France
Abstracts of ICPE 2023, the 39th international conference on pharmacoepidemiology and therapeutic risk management (ICPE), 25–27 August 2023, Halifax, Canada   12 octobre 2023
Drug-Induced Immune Hemolytic Anemia: Detection of New Signals and Risk Assessment in a Nationwide Cohort Study.
Blood advances   02 octobre 2023
Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.
Blood   22 septembre 2023
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study.
Expert opinion on drug safety   21 août 2023